Objective. The primary aim of this study is to determine the effect of adding dexamethasone, clonidine or both with and without epinephrine to ropivacaine and bupivacaine brachial plexus blocks.
Introduction
Postoperative pain is a major source of dissatisfaction for patients receiving surgical procedures [1] . Also, pain and nausea are among the leading causes of prolonged hospital stay and unplanned admissions following ambulatory surgery [2] [3] [4] . Regional anesthesia offers an effective and surgical site-specific option for surgical anesthesia and postoperative pain control after a wide variety of surgical procedures. Apart from offering better pain control, regional anesthesia reduces opioid requirements, minimizes nausea and vomiting, and expedites discharge [5, 6] .
Single-injection nerve blocks are widely used types of regional anesthetics that can provide both surgical anesthesia and excellent postoperative analgesia. Multiple adjuvant medications have been added to local anesthetics in an attempt to maximize duration and/or enhance the quality of single-injection nerve blocks [7, 8] . Evidence regarding the precise effects and efficacy of these adjuvants has been inconsistent. This disparity is likely due to small cohorts and confounding variables, including diversity of local anesthetics and adjuvants evaluated, peripheral nerve blocks (PNBs) studied, neuro-location techniques, combination of adjuvants, and patients' inherent variability in response [9] . Our institution has previously found that dexamethasone prolonged duration of PNBs (upper and lower extremity blocks) by 37% [10] . However, the choice of adjuvants to enhance particular PNBs remains a clinician preference due to lack of specific data on the effect of such medications on nerve block duration, especially when combinations are used. The primary aim of this study is to determine the effect of adding dexamethasone, clonidine, or both to ropivacaine brachial plexus block (BPB) duration in a single outpatient surgery center. The secondary aim is to determine the effect of adding epinephrine to ropivacaine BPB with and without other adjuvants.
Methods
After approval by the Institutional Review Board at Vanderbilt University Medical Center for Human Studies, data of all patients who received regional anesthesia at a single outpatient surgery center were collected prospectively over a six-year period (November 1, 2008, to October 31, 2014). The regional anesthesia database contains information collected and managed using the Research Electronic Data Capture (REDCap) tool at Vanderbilt University. It is a secure, Web-based application designed to support data capture for research studies. In addition, chart review was performed as needed for the few patients with missing demographic or nerve block data.
Patients received general anesthesia or sedation in conjunction with their regional anesthetic at the discretion of the attending anesthesiologist. General anesthesia was delivered via either inhaled volatile anesthetic or total intravenous infusion of propofol. Patients who did not receive general anesthesia were provided sedation with midazolam, fentanyl, and/or propofol as needed during the procedure. Additional intraoperative and postoperative analgesia was supplemented with fentanyl, ketorolac, and/or hydromorphone as needed by the patient's symptoms. Patients were discharged on oral opioid analgesics, acetaminophen, and/or nonsteroidal antiinflammatory agents per the surgeon's discretion. A senior regional anesthesia resident or regional anesthesia fellow collected block duration data by daily follow-up phone calls to patients within 48 hours following surgery. Postoperatively, patients were asked the time they started feeling pain at a level that required medication as a surrogate for block duration. Block duration was calculated by the difference between the time of block placement and the time when pain medications were first required.
We queried the REDCap Regional Anesthesia Database for all blocks performed during the six-year period detailed above. Demographic data included gender, age, and American Society of Anesthesiologists (ASA) status. Nerve block data included type of block (single or multiple), local anesthetic (concentration and volume), adjuvant/s (doses), success, presence of a pain catheter, duration of block, complications including postoperative neurologic symptoms, whether general anesthesia was combined with the regional anesthetic, and any additional free text comments added to the database. From the entire data set, only single-injection PNBs performed at the brachial plexus (interscalene, supraclavicular, infraclavicular, and axillary approaches) using ropivacaine were selected for the analysis. Multiple rescue, unsuccessful, and distal nerve blocks of the upper extremity were excluded. Patients were also excluded if they were lost to follow-up or had residual numbness lasting longer than 72 hours ( Figure 1 ).
Statistical Analysis
As block durations for all groups of additives used were not normally distributed, data are shown as means 6 standard deviation (SD) and graphed as median with 25% and 75% quartiles. Also, 1% trimmed means were used to more accurately describe the central tendency, minimize skewness, and to eliminate outliers [11] . The analysis was performed on the remaining 98% of data after excluding the 1% from each low and high end of tabulated block durations. To test the effect of additives, block durations were compared using analysis of variance (ANOVA). A post hoc test was performed to find differences of durations among different additives. Due to unequal group sizes, hoc tests were performed to adjust for multiple comparisons utilizing Hochberg's GT2 procedure. Analysis of covariance (ANCOVA) was carried out using a general linear model to control for other confounding variables. These included age, sex, ASA class, block location above or below clavicle, volume of local anesthetics, use of general anesthesia (GA), and adjuvants added. Also, a subgroup analysis using a general linear model was constructed in the dexamethasone groups (with and without epinephrine) to isolate the effect of different dexamethasone doses, or from adding epinephrine, on the block duration. A P value was considered significant if less than 0.05 after adjustment to control for type I error with multiple comparisons. The analyses were performed with SPSS software (version 22 for Mac; IBM, Armonk, NY, USA).
Results
There were 5,515 brachial plexus single-injection nerve blocks performed over the six-year period. After all exclusions, 3,706 nerve blocks were analyzed ( Figure 1 ). A total of 2,163 (58.4%) blocks were performed on males.
The mean age of patients was 44 6 17.2 years (quartiles ¼ 29/46/57 years). Eighty-three percent of patients were ASA classification I and II, while 18.8% were ASA III or higher (Table 1) .
No adjuvants were added to ropivacaine in 1,535 (41.4%) of patients. The median concentration of ropivacaine used was 0.5% (0.25-0.5%), and the median volume was 30 mL (quartiles ¼ 30/30/30 mL). Epinephrine was the sole adjuvant in 293 patients (7.9%) and was present with other adjuvants in 352 (9.5%) of the cohort. Epinephrine was added at a concentration of either 1:300,000 or 1:400,000 at the discretion of the clinician. Clonidine was used as an adjuvant in 527 patients (14.2%) without epinephrine and in 16 patients (0.4%) with epinephrine. When used, clonidine dose was 50 or 100 mg (Appendix 1). Dexamethasone was used as an adjuvant in 204 patients (5.5%) without epinephrine and 303 patients (8.2%) with epinephrine. The median dose of dexamethasone used was 4 mg (quartiles ¼ 2/4/8 mg). The mean dexamethasone dose was 4.0 mg when it was the only adjuvant used. The mean dexamethasone doses when used in combination with clonidine or epinephrine were 2.1 and 7.6 mg, respectively. Clonidine and dexamethasone were used together in 795 patients (21.5%) without epinephrine and in 33 patients (0.9%) with epinephrine.
The ANCOVA analysis showed that age independently increased block duration by 1.2 minutes for every year of age (P < 0.001). Volume of local anesthetic was also positively related to block duration and increased block duration by 4.2 min/mL (P < 0.001). Sex, ASA class, block location, and use of GA for surgery did not significantly alter block duration (Table 1) .
After adjusting for covariates, the mean BPB duration with ropivacaine alone was 15.4 6 4.7 hours. When epinephrine was added to ropivacaine, the block duration 
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did not significantly change, with mean block duration of 15.0 6 4.9 hours (P ¼ 0.24). When compared with ropivacaine alone, both clonidine and dexamethasone significantly increased block duration by 1.1 and 3.0 hours, respectively (P < 0.001). Combining clonidine and dexamethasone with ropivacaine increased block duration by an average of 6.2 hours (P < 0.001). The combination increased duration by 5.2 hours (P < 0.001) when compared with clonidine alone and 3.2 hours (P < 0.001) when compared with dexamethasone alone (Table 2 and Figure 2 ).
Epinephrine did not significantly change BPB duration when added to clonidine or the combination of clonidine and dexamethasone; it had a tendency to reduce duration by 0.6 and 1.9 hours (P ¼ 1 and P ¼ 0.72, respectively). However, it increased the duration when added to dexamethasone (increased duration by 1.9 hours, P < 0.001). A subgroup analysis was performed with dexamethasone dose and epinephrine use as covariates. This is due to the higher mean dexamethasone dose (6-8 mg) used with epinephrine compared with when dexamethasone was used alone (2-4 mg) (Table 3) . Neither dexamethasone dose nor epinephrine use independently reached statistical significance. However, dexamethasone dose was closer to statistical significance (P ¼ 0.11) when compared with epinephrine use (P ¼ 0.74). This indicates that adding epinephrine to dexamethasone did not independently increase the block duration.
Data for dexamethasone and clonidine doses used were incomplete. However, the available data were tabulated and plotted as median, 25% and 75% quartiles (box plot), and outliers against block duration (Appendix 1). General anesthesia had no effect on perceived duration of analgesia when compared with patients who underwent surgery with sedation only (Appendix 2). A comparison of the effect of adjuvants on block duration for BPB above and below the clavicle was graphed in Appendix 3. Ropivacaine volume effect on BPB duration in various adjuvant combinations is presented in Appendix 4. Additionally, dexamethasone dose with and without epinephrine is plotted against block duration in Appendix 5.
Discussion
Multiple adjuvant medications have been added to local anesthetics in order to increase duration and/or enhance the quality of single-injection nerve blocks. The data presented in this study come from the largest patient cohort of any other published work on the effect of adjuvants on brachial plexus block duration. We also included multiple combination comparisons of adjuvants in a single cohort using ropivacaine. In general, after adjusting for covariates, BPB duration was not prolonged by adding epinephrine at concentrations of 1:300,000 or 1:400,000.
There was a modest (1.1 hours) increase in duration when clonidine was added and a larger increase (3.0 hours) when dexamethasone was added. The largest increase (an average of 6.2 hours) was achieved when a combination of dexamethasone and clonidine was used.
Epinephrine is thought to increase the duration of peripheral nerve blockade due to decreased washout of the local anesthetics from the perineural area by epinephrine-induced vasoconstriction [9] . However, this decreased washout effect was not noted when epinephrine was added to ropivacaine for femoral threein-one block [12] or to many other amino-amides for intra-orbital block in rats [13] . While epinephrine may be useful as an intravascular injection marker or to decrease peak plasma concentration of local anesthetics, it has no significant effect on duration of PNBs using ropivacaine [14] or bupivacaine [15] . These previous findings are consistent with our results when epinephrine was added to plain ropivacaine or with other adjuvants. However, epinephrine was associated with the enhanced duration observed by dexamethasone. It is important to note that the mean dexamethasone dose used was higher in the epinephrine/dexamethasone group compared with dose used in other groups (8 mg vs 4 mg or less). The subgroup analysis showed that the higher dose of dexamethasone used with epinephrine had a stronger effect (although statistically insignificant) compared with epinephrine addition. Interestingly, Tandoc et al. found no difference in block duration when 4 or 8 mg of dexamethasone were added to bupivacaine for interscalene nerve blocks [16] . Epinephrine has been shown to increase perineural blood flow at low concentrations (1:400,000) [17] . This dose-dependent effect of epinephrine may explain the trend toward reduction in block duration in our study where we used concentrations of either 1:300,000 epinephrine or less for all nerve blocks.
Some of the variability surrounding the observed epinephrine effect may be due to inconsistent dilution of the epinephrine or interactions between the dose of dexamethasone and the dose of epinephrine.
The role of neuraxial clonidine in both the intrathecal and epidural spaces is well established in the literature. However, its role as an adjuvant to PNBs is controversial [18] and is outside the scope of its prescribing label. A meta-analysis of the effect of clonidine added to longacting local anesthetics for plexus and nerve blocks found a mean of 2.5 hours' prolongation of postoperative analgesia [19] . In our study, clonidine had less effect, with a Figure 2 Median, 25% quartile, and 75% quartile (box plot) with suspected outliers (circles), duration of ropivacaine postoperative analgesia with and without adjuvants.
mean increase of block duration of 1.2 hours. This difference may be because the meta-analysis included both upper and lower extremity nerve blocks and included levobupivacaine, which was associated with a longer duration when clonidine was added. In addition, we adjusted for covariates (e.g., age) in our analysis where others did not.
Dexamethasone is another adjuvant commonly used to prolong duration of analgesia in both upper and lower extremity PNBs [10, 20, 21] . In a recent meta-analysis, dexamethasone increased short-or medium-acting local anesthetic duration of analgesia by an average of 3.8 hours and long-acting local anesthetic duration by an average of 8.1 hours [22] . In another study of interscalene blocks, dexamethasone increased analgesia by nearly 12 hours and increased motor block by almost 15 hours [16] . In a previous preliminary analysis of the effect of dexamethasone from our database, Rasmussen et al. showed a median increase of six hours in block duration when dexamethasone was added for upper and lower extremity PNBs [10] . In this study of brachial plexus blocks, dexamethasone was the most effective single adjuvant used to prolong the duration of ropivacaine (3.0 hours), and adding clonidine to dexamethasone resulted in an additional increase of duration, up to an average of 6.2 hours. We used trimmed means and excluded BPBs lasting more than 48 hours, which may reflect more accurately the central tendency of dexamethasone effect on block duration. Although some studies have shown that dexamethasone appears safe perineurally, it is not approved by the US Food and Drug Administration for peripheral nerve block use, and safety data are incomplete; therefore, it is still considered off-label use and caution must be exercised [23] . There are also additional studies with mixed results that attempt to determine whether the analgesic benefits from dexamethasone are from a local and/or a systemic effect [23] . The prolongation of BPB analgesic duration of up to six hours with adjuvants may be of clinical relevance. The overall extended analgesia may result in less systemic medication use and better quality of pain control. As the potential risk of neural toxicity with adjuvants still needs to be fully investigated, each individual patient risk/benefit profile should be carefully considered.
An interesting and unique finding, not described before, is the effect of age on prolonging nerve block duration. Also, the results demonstrated that the larger the volume of ropivacaine used, the longer the block duration, complicating discussions of minimum effective volume for blocks [24] . This is the largest cohort with prospectively collected data comparing duration of BPBs according to adjuvants added. The data were collected in a real-life practice, and block duration was evaluated according to patients' perceptions. Refinement of our understanding in this area will require more studies to thoroughly evaluate the subtle effects of adding different adjuvants to local anesthetics. These studies must include the effect of different combinations and concentrations of adjuvants in order to optimize both efficacy and safety of single-injection PNBs.
As with all observational studies, there are limitations inherent to the study design. These include lack of randomization and the inability to control for all confounders. The results presented do show an association but do not imply direct causation. We focused only on BPBs and limited the analysis to one agent, ropivacaine, to minimize confounding created by different and combined local anesthetics. While we found no significant effect of the anesthetic type used, we did not account for oral and intravenous analgesic medications used both during the operation and afterwards, which may affect the duration of analgesia perceived by patients. There could also be an information bias related to precision of the duration of postoperative analgesia, as reported by patient questioning. However, we believe that the patient's report of duration, including their self-titration of oral analgesics, is an important clinical reflection of their perception of pain. Finally, this study focused on the efficacy of adjuvants and not their safety, which will be addressed in another ongoing analysis of the same cohort. It is important to recognize that while a significant P value is an indication that the effect detected is less likely due to chance, it does not eliminate it. In addition, a statistically significant result does not always translate to a clinically relevant one. Hence the results presented in this work should be interpreted accordingly.
Conclusions
Dexamethasone and/or clonidine, added as adjuvants, prolong the duration of postoperative analgesia of ropivacaine BPB, but dexamethasone is the most effective. Combining clonidine and dexamethasone for ropivacaine BPB provides an additional duration advantage compared with either adjuvant alone. Epinephrine does not affect the duration of analgesia of BPBs when added to ropivacaine with or without other adjuvants. Figure A4 Median, 25% quartile, and 75% quartile (box plot) with suspected outliers (circles), duration of ropivacaine postoperative analgesia for BPB above and below clavicle. Figure A5 Median, 25% quartile, and 75% quartile (box plot) with suspected outliers (circles), duration of ropivacaine postoperative analgesia in three ropivacaine volume subgroups with and without added adjuvants. Figure A6 Median, 25% quartile, and 75% quartile (box plot) with suspected outliers (circles), duration of ropivacaine postoperative analgesia clustered by epinephrine use in various dexamethasone dosing.
